Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral isotretinoin for rhinoplasty outcomes in adults with thick nasal skin
IRCT20251129068154N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of isotretinoin in None (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Rhinoplasty Outcome Evaluation and Presence or absence of hypertrophic scar or keloid. Started Jan 2026; status: completed.
02
Drugs
isotretinoin
Beyond the preview
Go deeper on IRCT20251129068154N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251129068154N1.